Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Aviron-NeuroVir gene therapy alliance

Oct. 25, 1996

Selective killing of p53-deficient human tumor cells with mutant adenovirus

Oct. 25, 1996

NIH seeks to license invention related to compounds inducing apoptosis

Oct. 25, 1996

Japanese researchers disclose anticancer applications of the E1AF gene

Oct. 25, 1996

NIH seeks licensees for novel laminin molecule that lacks affinity for collagen IV

Oct. 25, 1996

GV-1301 and GV-1302 available for licensing

Oct. 25, 1996

Follow-up confirms safety of PN-27.1

Oct. 25, 1996

New antitumor agent from Banyu

Oct. 25, 1996

CRC Technology reports antitumor activity of DF-203

Oct. 25, 1996

DAG analogues as potent PKC agonists available for licensing

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...